miR-21: a promising biomarker for the early detection of colon cancer
Open Access
- 1 July 2019
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 12, 5601-5607
Abstract
Purpose: The aim of this study was to compare the expression of miR-21 gene in stages II-IV of formalin-fixed paraffin-embedded (FFPE) tissue in patients with colon cancer and introduce miR-21 as a potential molecular marker for detection of colon cancer in the early stages. Introduction: Currently, identification of key molecules involved in the pathogenesis of cancer is one of the areas under consideration. miRNAs, are small RNAs which have been identified in many cancers. In this study, we investigated the expression of miR-21 in three pathologic stages in patients with colon cancer in the north of Iran. Patients and methods: A total of 40 FFPE samples were obtained from patients with stages II, III, and IV from hospitals in Mazandaran and Golestan provinces. After extraction of RNA, treatment with DNase I and cDNA synthesis was performed and miR-21 expression was assessed by qPCR. Then, the data were analyzed using statistical software R (3.4.3). Results: The expression of miR-21 in stage II was significantly different from stage IV. However, no significant difference was observed between the other stages. In stage II, the level of miR-21 expression was higher in men than women. Moreover, in the second pathological stage, miR-21 expression was reduced in patients with adjacent lymphoid tissue engagement. In addition, the expression of miR-21 in grade I was significantly higher than grade II. Conclusion: The results of this study suggest that miR-21 can be a diagnostic marker for early stages of colon cancer, especially in men. It can also be considered as a good candidate for targeted treatment of colon cancer in the early stages of the disease. Furthermore, for the first time, we suggested that miR-21 can be a good molecular marker for classification of the stages of colon cancer.Keywords
This publication has 44 references indexed in Scilit:
- Sex disparities in colorectal cancer incidence by anatomic subsite, race and ageInternational Journal of Cancer, 2011
- High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patientsClinical & Experimental Metastasis, 2010
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21Cancer Cell, 2010
- microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer CellsCancer Research, 2009
- Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon AdenocarcinomaClinical Cancer Research, 2009
- miR-21: An Androgen Receptor–Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer GrowthCancer Research, 2009
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase RegulatorsMolecular and Cellular Biology, 2008
- Differential Expression of PTEN-Targeting MicroRNAs miR-19a and miR-21 in Cowden SyndromeThe American Journal of Human Genetics, 2008
- MicroRNA expression profiles classify human cancersNature, 2005